Whalegun
Home

Regeneron Pharmaceuticals REGN paid Checkmate Government Relations $90K for lobbying in Q1 2026 · Health Issues

Trade details

Type
Lobbying report
Amount
$90,000
Quarter
Q1 2026
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
26/04/15

Up 0.0% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN paid Checkmate Government Relations $90K for lobbying in Q1 2026 · Health Issues | Whalegun